Ganglioside treatment of neuropathy in diabetic mice
Authors:
- Roberto CanellaRCRoberto Canella
- 1 February 1982
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 5 (2) , 107-110
Abstract
Diabetic neuropathy in 180‐day‐old C57BL/Ks inbred mice is characterized by a marked reduction of nerve conduction velocity (NCV) and by axonal atrophy, as suggested by the decreased number of large diameter myelinated fibers. No demyelination or remyelination was observed. Ganglioside treatment from 150 to 180 days of age significantly improved the NCV and returned the fiber size distribution to control values.Keywords
This publication has 25 references indexed in Scilit:
- Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growthBrain Research, 1980
- Axoplasmic transport of noradrenaline in the sciatic nerves of spontaneously diabetic miceDiabetologia, 1979
- Pathology and time relationship of peripheral nerve changes in experimental diabetesJournal of the Neurological Sciences, 1977
- Peripheral motor nerve function in diabetic autonomic neuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- Painful Diabetic NeuropathyArchives of Neurology, 1976
- THE PATHOGENESIS OF SURAL NERVE CHANGES IN DIABETES MELLITUSBrain, 1969
- Zur Pathologie des peripheren Nervensystems beim Alloxandiabetes des HundesJournal of Neural Transmission, 1967
- Studies with the mutation, diabetes, in the mouseDiabetologia, 1967
- Nerve Conduction Changes in Experimental Diabetes*Journal of Clinical Investigation, 1964
- Sensory nerve conduction in patients with diabetes mellitus and controlsNeurology, 1961